J&J Ordered To Pay $40M In Damages In Antitrust Suit
A group of patients diagnosed with inflammatory diseases will receive almost $40 million from Johnson & Johnson after a Pennsylvania federal judge gave final approval to a settlement over accusations that...To view the full article, register now.
Already a subscriber? Click here to view full article